Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis

INTRODUCTION: Beta-blockers are recommended by the European Society of Cardiology as first-line antianginal therapy for reducing heart rate (HR) and symptoms in patients with chronic coronary syndrome, despite a lack of data showing superiority to other antianginal agents. Most patients with angina...

Descripción completa

Detalles Bibliográficos
Autores principales: Nedoshivin, Alexander, Petrova, Parvoleta T. S., Karpov, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402524/
https://www.ncbi.nlm.nih.gov/pubmed/35842897
http://dx.doi.org/10.1007/s12325-022-02222-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402524/
https://www.ncbi.nlm.nih.gov/pubmed/35842897
http://dx.doi.org/10.1007/s12325-022-02222-1

Ejemplares similares